Shares of ImmunoGen spiked 14.2% on Monday after the biotechnology company said that the U.
ImmunoGen, Inc. (NASDAQ:IMGN) shares are rallying today thanks to news of a collaboration agreement with Jazz Pharmaceuticals (NASDAQ:JAZZ) for the development and commercialization …
ImmunoGen, Inc. (NASDAQ:IMGN), a biotechnology company that develops targeted anticancer therapeutics using its proprietary ADC technology, today reported financial results for the three-month …
In a research report sent to investors, Cantor analyst Mara Goldstein reiterated a Hold rating on ImmunoGen (NASDAQ:IMGN) with a $9.00 price target, following …
In a research report published Monday, Cantor analyst Mara Goldstein maintained a Hold rating on ImmunoGen (NASDAQ:IMGN) and reduced her price target to $9 (from $14), …
In a research note published Monday, Oppenheimer analyst Christopher Marai assigned a Perform rating on ImmunoGen (NASDAQ:IMGN), No price target was provided. Marai commented: “ImmunoGen reported …
In a research report issued today, William Blair analyst John Sonnier assigned an Outperform rating on ImmunoGen (NASDAQ:IMGN). No price target was provided.
